Free Trial
The Rate Lock Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 a Year
Claim MarketBeat All Access Sale Promotion

Option Care Health, Inc. (OPCH) - What Are Analysts Saying About This Stock?

Option Care Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst consensus is “Hold”: Fourteen of 16 analysts rate Option Care Health shares a hold, while two recommend buying. The average 12-month price target is $29.48, below the reported share price of $31.85.
  • Institutional ownership is substantial: Hedge funds and other institutional investors own approximately 98.05% of the company, with several firms recently initiating or increasing positions.
  • Recent results exceeded expectations: Option Care Health reported quarterly earnings of $0.45 per share versus the $0.43 consensus estimate, while revenue reached $1.44 billion and increased 1.9% year over year.
  • Five stocks to consider instead of Option Care Health.

Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have earned a consensus rating of "Hold" from the sixteen brokerages that are currently covering the stock, Marketbeat reports. Fourteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $29.48.

Several brokerages have commented on OPCH. Wall Street Zen upgraded Option Care Health from a "hold" rating to a "buy" rating in a research note on Saturday, August 1st. JPMorgan Chase & Co. cut Option Care Health from an "overweight" rating to a "neutral" rating and set a $33.00 price target on the stock. in a research report on Wednesday, October 7th. Zacks Research raised shares of Option Care Health from a "strong sell" rating to a "hold" rating in a report on Monday, July 6th. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and raised their price objective for the company from $28.00 to $32.05 in a research report on Tuesday, October 6th. Finally, Weiss Ratings upgraded shares of Option Care Health from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday, October 20th.

Get Our Latest Stock Analysis on OPCH

Institutional Trading of Option Care Health

Several institutional investors and hedge funds have recently modified their holdings of OPCH. Reyes Financial Architecture Inc. bought a new position in shares of Option Care Health in the third quarter worth approximately $28,000. Harbor Investment Advisory LLC purchased a new stake in Option Care Health in the second quarter valued at approximately $48,000. Nykredit A S bought a new stake in Option Care Health during the second quarter valued at approximately $56,000. Nisa Investment Advisors LLC lifted its position in Option Care Health by 268.9% during the third quarter. Nisa Investment Advisors LLC now owns 2,955 shares of the company's stock valued at $66,000 after purchasing an additional 2,154 shares during the last quarter. Finally, Public Employees Retirement System of Ohio bought a new stake in Option Care Health during the second quarter valued at approximately $66,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Stock Up 1.8%

Shares of NASDAQ OPCH opened at $31.85 on Friday. The stock has a market capitalization of $4.77 billion, a PE ratio of 23.95, a P/E/G ratio of 1.90 and a beta of 0.58. Option Care Health has a one year low of $18.01 and a one year high of $36.80. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. The business's fifty day moving average price is $26.34 and its 200-day moving average price is $26.47.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company's revenue was up 1.9% on a year-over-year basis. During the same quarter last year, the company earned $0.41 earnings per share. On average, equities research analysts anticipate that Option Care Health will post 1.70 EPS for the current year.

About Option Care Health

(Get Free Report)

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients' homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.

Featured Articles

Analyst Recommendations for Option Care Health (NASDAQ:OPCH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines